| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.05B | 6.12B | 6.26B | 6.04B | 5.81B | 4.92B |
| Gross Profit | 2.32B | 2.32B | 2.35B | 2.43B | 2.43B | 2.11B |
| EBITDA | 292.29M | 7.05M | -971.83M | 407.75M | 452.22M | 352.36M |
| Net Income | -28.20M | -101.82M | -1.28B | 90.80M | 164.42M | -26.48M |
Balance Sheet | ||||||
| Total Assets | 5.15B | 5.19B | 5.36B | 6.61B | 6.50B | 6.08B |
| Cash, Cash Equivalents and Short-Term Investments | 188.75M | 165.76M | 125.43M | 201.90M | 211.60M | 111.40M |
| Total Debt | 2.94B | 2.94B | 3.04B | 3.13B | 3.05B | 3.00B |
| Total Liabilities | 4.01B | 4.08B | 4.18B | 4.23B | 4.24B | 4.02B |
| Stockholders Equity | 1.14B | 1.11B | 1.18B | 2.38B | 2.27B | 2.07B |
Cash Flow | ||||||
| Free Cash Flow | 58.68M | 49.68M | -9.88M | 67.98M | 119.11M | 109.06M |
| Operating Cash Flow | 187.16M | 177.67M | 215.72M | 346.00M | 358.21M | 268.62M |
| Investing Cash Flow | -123.93M | -123.90M | -207.44M | -320.32M | -237.08M | -157.19M |
| Financing Cash Flow | -7.14M | -8.75M | -85.35M | -33.84M | -18.78M | -146.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
| ― | $13.99B | 95.15 | 34.48% | ― | 9.04% | -56.79% | |
| ― | $154.22M | ― | -26.91% | ― | -3.08% | 14.42% | |
| ― | $1.08B | ― | -58.93% | ― | -10.39% | 14.92% | |
| ― | $891.22M | ― | -2.48% | ― | -2.83% | 97.94% | |
| ― | $50.20M | 143.89 | 1.05% | 18.35% | -2.07% | -61.05% | |
| ― | $229.20M | -1.04 | -67.22% | ― | -8.07% | -2206.16% |
Petco Health and Wellness Company Inc. recently held its earnings call, revealing a balanced sentiment between internal improvements and external challenges. The company showcased significant strides in profitability and operational efficiency, yet faces hurdles in achieving top-line growth amid tough sales comparisons and tariff impacts in the latter half of the year.
Petco Health and Wellness Company Inc., a leading retailer in the pet care industry, offers a wide range of products and services for pet owners across the U.S., Mexico, and Puerto Rico. The company is known for its extensive selection of pet supplies, expert support, and commitment to animal welfare.
Petco announced its financial results for the second quarter of 2025, reporting net sales of $1.5 billion, a 2.3% decrease year over year, and a gross profit margin increase to 39.3%. Despite the decline in sales, the company improved its operating income and net income, leading to an increased earnings outlook for the fiscal year 2025. Petco plans to continue its strategic investments to drive sustainable growth and maintain its competitive position in the market.
The most recent analyst rating on (WOOF) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.
On August 21, 2025, Petco Health and Wellness Company announced its participation in the 32nd Annual Goldman Sachs Global Retailing Conference scheduled for September 4, 2025. The company will present at the conference, with a live webcast available on its investor relations page. This participation highlights Petco’s active engagement in the retail industry and its commitment to maintaining visibility and communication with stakeholders.
The most recent analyst rating on (WOOF) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Petco Health and Wellness Company stock, see the WOOF Stock Forecast page.